Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Interchangeability: Stakeholders Want More FDA Guidance, Fewer Hurdles

Related Content

FDA Biosimilars Guidances Address Immunogenicity Studies, European Bridge Data, Analytics

Feb 13 2012

Waxman Says Biosimilar Pathway Will Push Applicants To BLA

Nov 22 2010

Biosimilars May Drift, But What Should FDA Do About It?

Nov 15 2010

Related Companies

Express Scripts Holding Company

CVS Health Corp.

Viatris Inc.

Apotex Inc.

Allergan plc

Amgen, Inc.

Johnson & Johnson

Johnson & Johnson

Additional Topics

United States Drug Approval Standards BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window